ALL vs APVO · P/E 4.9, rev $18.60B vs $9.9M cap
The Allstate Corporation (ALL) versus Aptevo Therapeutics Inc (APVO) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
APVO does not have a complete income-statement cache yet.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. APVO currently screens at market cap $9.9M.
Not investment advice. Open the ALL and APVO stock pages for the full models.
Not investment advice.